News Conference News TCT 2020 Robotic PCI Can Protect Cath Lab Staff From COVID-19, Small Study Suggests Todd Neale October 22, 2020
News Conference News TCT 2020 While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry L.A. McKeown October 21, 2020
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Conference News TCT 2020 Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results Todd Neale October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News TCT 2020 STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI Caitlin E. Cox October 14, 2020
News Conference News TCT 2020 OCT Proves Predictive in Diabetic Patients, Even in FFR-Negative Lesions Shelley Wood October 14, 2020
Presentation TCT 2020 TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) Presenter: Jason Nogic October 14, 2020
Presentation TCT 2020 TCT 304: Meta-Analysis of Long-term Outcomes in Patients With Diabetes Mellitus and Left Main Coronary Artery Disease Treated With Drug-eluting Stent Versus Coronary Artery Bypass Grafting Presenter: Abdullah Al-abcha October 14, 2020
Presentation TCT 2020 TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial. Presenter: Elvin Kedhi October 14, 2020
Presentation TCT 2020 TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Adrian Wlodarczak October 14, 2020